Summary: We present evidence that (1) viral respiratory infections are potential mechanisms of ACE2 overexpression in patients with asthma and (2) ACE activation regulates multiple cytokine anti-viral responses that could explain a mechanism for cytokine surge and associated tissue damage. These results suggest that the recent finding of severe COVID-19 in asthma patients with recent exacerbations may be attributable to synergistic biomolecular interactions with viral co-infections.
Overall Design: In a paired design experiments across discovery and validation cohorts of in asthmatic patients the biological replicates treated with RVA and RVC were compared to non-treated ones.
Strategy: |
|
Species: |
|
Tissue: |
|
Healthy Condition: |
|
Growth Protocol: | We developed well-differentiated ciliated air-liquid interface (ALI) cultures from nasal tissues biopsied from thirty adults with physician-diagnosed asthma. |
Treatment Protocol: | - |
Extract Protocol: | RNA was extracted from whole-cell lysates, mapped to the UCSC transcript set using Bowtie2 (v2.1.0) and the gene expression level was estimated using standard techniques. |
Library Construction Protocol: | Libraries for RNA-Seq were prepared with Kapa Stranded mRNA. The workflow consisted of mRNA enrichment, cDNA generation, and end repair to generate blunt ends, A-tailing, adaptor ligation and PCR amplification. Different adaptors were used for multiplexing samples in one lane. |
Molecule Type: | rRNA- RNA |
Library Source: | |
Library Layout: | SINGLE |
Library Strand: | Forward |
Platform: | ILLUMINA |
Instrument Model: | Illumina HiSeq 3000 |
Strand-Specific: | Specific |
Data Resource | GEN Sample ID | GEN Dataset ID | Project ID | BioProject ID | Sample ID | Sample Name | BioSample ID | Sample Accession | Experiment Accession | Release Date | Submission Date | Update Date | Species | Race | Ethnicity | Age | Age Unit | Gender | Source Name | Tissue | Cell Type | Cell Subtype | Cell Line | Disease | Disease State | Development Stage | Mutation | Phenotype | Case Detail | Control Detail | Growth Protocol | Treatment Protocol | Extract Protocol | Library Construction Protocol | Molecule Type | Library Layout | Strand-Specific | Library Strand | Spike-In | Strategy | Platform | Instrument Model | Cell Number | Reads Number | Gbases | AvgSpotLen1 | AvgSpotLen2 | Uniq Mapping Rate | Multiple Mapping Rate | Coverage Rate |
---|